Subsequent Surgery After Revision Anterior Cruciate Ligament Reconstruction: Rates and Risk Factors From a Multicenter Cohort.

Published

Journal Article

BACKGROUND: While revision anterior cruciate ligament reconstruction (ACLR) can be performed to restore knee stability and improve patient activity levels, outcomes after this surgery are reported to be inferior to those after primary ACLR. Further reoperations after revision ACLR can have an even more profound effect on patient satisfaction and outcomes. However, there is a current lack of information regarding the rate and risk factors for subsequent surgery after revision ACLR. PURPOSE: To report the rate of reoperations, procedures performed, and risk factors for a reoperation 2 years after revision ACLR. STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: A total of 1205 patients who underwent revision ACLR were enrolled in the Multicenter ACL Revision Study (MARS) between 2006 and 2011, composing the prospective cohort. Two-year questionnaire follow-up was obtained for 989 patients (82%), while telephone follow-up was obtained for 1112 patients (92%). If a patient reported having undergone subsequent surgery, operative reports detailing the subsequent procedure(s) were obtained and categorized. Multivariate regression analysis was performed to determine independent risk factors for a reoperation. RESULTS: Of the 1112 patients included in the analysis, 122 patients (11%) underwent a total of 172 subsequent procedures on the ipsilateral knee at 2-year follow-up. Of the reoperations, 27% were meniscal procedures (69% meniscectomy, 26% repair), 19% were subsequent revision ACLR, 17% were cartilage procedures (61% chondroplasty, 17% microfracture, 13% mosaicplasty), 11% were hardware removal, and 9% were procedures for arthrofibrosis. Multivariate analysis revealed that patients aged <20 years had twice the odds of patients aged 20 to 29 years to undergo a reoperation. The use of an allograft at the time of revision ACLR (odds ratio [OR], 1.79; P = .007) was a significant predictor for reoperations at 2 years, while staged revision (bone grafting of tunnels before revision ACLR) (OR, 1.93; P = .052) did not reach significance. Patients with grade 4 cartilage damage seen during revision ACLR were 78% less likely to undergo subsequent operations within 2 years. Sex, body mass index, smoking history, Marx activity score, technique for femoral tunnel placement, and meniscal tearing or meniscal treatment at the time of revision ACLR showed no significant effect on the reoperation rate. CONCLUSION: There was a significant reoperation rate after revision ACLR at 2 years (11%), with meniscal procedures most commonly involved. Independent risk factors for subsequent surgery on the ipsilateral knee included age <20 years and the use of allograft tissue at the time of revision ACLR.

Full Text

Duke Authors

Cited Authors

  • MARS Group, ; Ding, DY; Zhang, AL; Allen, CR; Anderson, AF; Cooper, DE; DeBerardino, TM; Dunn, WR; Haas, AK; Huston, LJ; Lantz, BBA; Mann, B; Spindler, KP; Stuart, MJ; Wright, RW; Albright, JP; Amendola, AN; Andrish, JT; Annunziata, CC; Arciero, RA; Bach, BR; Baker, CL; Bartolozzi, AR; Baumgarten, KM; Bechler, JR; Berg, JH; Bernas, GA; Brockmeier, SF; Brophy, RH; Bush-Joseph, CA; Butler, JB; Campbell, JD; Carey, JL; Carpenter, JE; Cole, BJ; Cooper, JM; Cox, CL; Creighton, RA; Dahm, DL; David, TS; Flanigan, DC; Frederick, RW; Ganley, TJ; Garofoli, EA; Gatt, CJ; Gecha, SR; Giffin, JR; Hame, SL; Hannafin, JA; Harner, CD; Harris, NL; Hechtman, KS; Hershman, EB; Hoellrich, RG; Hosea, TM; Johnson, DC; Johnson, TS; Jones, MH; Kaeding, CC; Kamath, GV; Klootwyk, TE; Levy, BA; Ma, CB; Maiers, GP; Marx, RG; Matava, MJ; Mathien, GM; McAllister, DR; McCarty, EC; McCormack, RG; Miller, BS; Nissen, CW; O'Neill, DF; Owens, BD; Parker, RD; Purnell, ML; Ramappa, AJ; Rauh, MA; Rettig, AC; Sekiya, JK; Shea, KG; Sherman, OH; Slauterbeck, JR; Smith, MV; Spang, JT; Svoboda, SJ; Taft, TN; Tenuta, JJ; Tingstad, EM; Vidal, AF; Viskontas, DG; White, RA; Williams, JS; Wolcott, ML; Wolf, BR; York, JJ

Published Date

  • July 2017

Published In

Volume / Issue

  • 45 / 9

Start / End Page

  • 2068 - 2076

PubMed ID

  • 28557557

Pubmed Central ID

  • 28557557

Electronic International Standard Serial Number (EISSN)

  • 1552-3365

Digital Object Identifier (DOI)

  • 10.1177/0363546517707207

Language

  • eng

Conference Location

  • United States